Morning Buzz: Apple (AAPL), Cytokinetics (CYTK), NephroGenex (NRX), RedHill Biopharma (RDHL), Pacific Ethanol (PEIX)

Apple Inc. (AAPL) — According to the latest forecasts from market intelligence firm ABI Research, the tech giant is on track to post its first yearly decline in iPad sales since the device was introduced. But the report also said Cupertino should reverse that trend in 2015, with overall tablet sales rising 16%. “Historically, Apple […] View the full post at: Morning Buzz: Apple (AAPL), Cytokinetics (CYTK), NephroGenex (NRX), RedHill Biopharma (RDHL), Pacific Ethanol (PEIX) Related posts: Apple iPad Sales Hit 1 Million Just 28 Days After its Introduction Apple to Use AMD Chips? Apple’s iPhone Software to Deliver Multitasking Support
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.